SciSparc Ltd. (SPRC) income statement
SPRCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.30+0.03 (+11.07%)
Close on Nov 19, 2026Market cap $109.63KP/E 0.0Yield –
SciSparc Ltd. financial ratios
See a number that looks wrong?
Close on Nov 19, 2026Market cap $109.63KP/E 0.0Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||||
| Gross margin | 73.7% | 38.7% | 76.3% | 76.1% | – | – | – | – | – | – | – | – |
| Operating margin | -978.3% | -560.2% | -236.7% | -615.2% | – | – | – | – | – | – | – | – |
| EBITDA margin | -950.9% | -523.3% | -218.0% | -601.3% | – | – | – | – | – | – | – | – |
| Pre-tax margin | -1,467.8% | -573.2% | -203.6% | -191.4% | – | – | – | – | – | – | – | – |
| Net profit margin | -1,422.8% | -481.2% | -177.9% | -192.4% | – | – | – | – | – | – | – | – |
| Free cash flow margin | – | – | – | -588.3% | – | – | – | – | – | – | – | – |
| Returns on capital | ||||||||||||
| Return on equity | -196.5% | -79.7% | -72.8% | -35.5% | -121.0% | 489.6% | 4,709.5% | -208.0% | -139.3% | -230.7% | -504.2% | – |
| Return on assets | -135.6% | -58.4% | -47.0% | -25.3% | -92.8% | 190.3% | 164.0% | 92.5% | 115.5% | 160.1% | – | – |
| Return on tangible assets | -155.9% | -67.7% | -66.5% | -46.8% | -92.8% | 190.3% | 164.0% | 92.5% | 115.5% | 160.1% | – | – |
| Return on invested capital | -725.4% | – | – | – | – | 793.1% | – | – | – | – | – | – |
| Return on capital employed | -117.0% | -78.8% | -84.9% | -113.5% | -120.3% | -428.2% | -4,441.1% | -171.1% | -128.4% | -349.0% | – | – |
| Return on total capital | -152.2% | – | – | – | – | -203.5% | – | – | – | – | – | – |
| NOPAT | -$6.62M | -$5.78M | -$5.38M | -$6.55M | -$4.56M | -$2.60M | -$3.25M | -$5.72M | -$4.55M | -$1.58M | $2.03M | – |
| Cash flow quality | ||||||||||||
| OCF / Sales | -483.3% | -390.8% | -204.5% | -587.8% | – | – | – | – | – | – | – | – |
| OCF / Net income | 0.34 | 0.81 | 1.15 | 3.05 | 0.87 | -1.22 | -1.00 | -1.09 | -0.73 | -0.74 | -0.55 | – |
| FCF / OCF | – | – | – | 100.1% | 100.7% | – | 100.0% | 100.2% | 101.0% | 100.3% | 100.1% | – |
| FCF / Net income | – | – | – | 3.06 | 0.88 | – | -1.00 | -1.09 | -0.74 | -0.74 | -0.55 | – |
| FCF / EBITDA | – | – | – | 97.8% | 88.9% | – | 119.5% | 100.8% | 80.4% | 74.0% | -54.7% | – |
| Unlevered free cash flow | – | – | – | -$6.33M | -$5.08M | – | -$4.16M | -$7.05M | -$4.24M | -$1.47M | -$1.41M | – |
| Levered free cash flow | – | – | – | -$7.93M | -$5.10M | – | -$4.70M | -$7.15M | -$4.62M | -$1.48M | -$1.41M | – |
| Efficiency | ||||||||||||
| Asset turnover | 0.10 | 0.12 | 0.26 | 0.13 | – | – | – | – | – | – | – | – |
| Fixed asset turnover | 21.95 | 15.64 | 34.90 | 18.08 | – | – | – | – | – | – | – | – |
| Receivables turnover | 85.60 | 81.63 | 58.16 | 0.90 | – | – | – | – | – | – | – | – |
| Days sales outstanding | 4.3 | 4.5 | 6.3 | 403.9 | – | – | – | – | – | – | – | – |
| Payables turnover | 0.88 | 3.75 | 3.61 | 1.86 | – | – | – | – | – | – | – | – |
| Days payables outstanding | 415.3 | 97.4 | 101.0 | 196.7 | – | – | – | – | – | – | – | – |
| Inventory turnover | 2.39 | 1.87 | 0.97 | 0.48 | – | – | – | – | – | – | – | – |
| Days inventory outstanding | 152.5 | 195.0 | 376.8 | 757.2 | – | – | – | – | – | – | – | – |
| Operating cycle | 156.8 | 199.5 | 383.0 | 1,161.1 | – | – | – | – | – | – | – | – |
| Cash conversion cycle | -258.5 | 102.1 | 282.0 | 964.4 | – | – | – | – | – | – | – | – |
| CapEx to revenue | – | – | – | 0.59% | – | – | – | – | – | – | – | – |
| CapEx to OCF | – | – | – | -0.10% | -0.69% | – | -0.02% | -0.24% | -0.96% | -0.27% | -0.14% | – |
| CapEx to depreciation | – | – | – | 0.04 | 1.06 | – | 0.01 | 0.12 | 8.80 | 1.00 | 0.67 | – |
| Liquidity | ||||||||||||
| Current ratio | 2.41 | 5.36 | 4.10 | 1.09 | 5.59 | 2.25 | 0.91 | 0.54 | 8.07 | 1.20 | – | – |
| Quick ratio | 2.38 | 5.28 | 3.63 | 0.92 | 5.59 | 2.25 | 0.91 | 0.54 | 8.07 | 1.20 | – | – |
| Cash ratio | 2.04 | 1.10 | 1.32 | 0.86 | 3.91 | 1.72 | 0.83 | 0.33 | 7.81 | 1.01 | – | – |
| Working capital | $3.18M | $6.10M | $4.87M | $354.00K | $8.07M | $1.42M | -$91.00K | -$2.05M | $8.32M | $132.00K | – | – |
| Net current asset value | $2.96M | $6.10M | $4.85M | $354.00K | $8.05M | $1.42M | -$185.00K | -$2.05M | $8.32M | $132.00K | – | – |
| Leverage | ||||||||||||
| Total debt | $356.00K | – | – | – | – | $188.00K | – | – | – | – | – | – |
| Net debt | -$4.24M | – | – | – | – | -$1.76M | – | – | – | – | – | – |
| Debt / Equity | 0.08 | – | – | – | – | 0.13 | – | – | – | – | – | – |
| Debt ratio | 4.7% | – | – | – | – | 7.3% | – | – | – | – | – | – |
| Assets to equity | 1.80 | 1.27 | 1.47 | 1.64 | 1.22 | 1.79 | 82.43 | 24.65 | 1.14 | 2.17 | – | – |
| Total debt / Capitalization | 7.7% | – | – | – | – | 11.6% | – | – | – | – | – | – |
| Net debt / EBITDA | 0.52 | – | – | – | – | 0.56 | – | – | – | – | – | – |
| Total debt / EBITDA | -0.04 | – | – | – | – | -0.06 | – | – | – | – | – | – |
| Cash flow to debt | -1,162.1% | – | – | – | – | -2,291.0% | – | – | – | – | – | – |
| Intangibles to total assets | 15.4% | 14.3% | 28.5% | 44.5% | – | – | – | – | – | – | – | – |
| Interest coverage | ||||||||||||
| EBIT / Interest expense | -1.02 | -20.73 | -6.46 | -4.11 | -274.67 | -3.78 | -6.08 | -59.84 | -11.72 | -250.00 | 284.89 | – |
| EBITDA / Interest expense | -0.99 | -19.36 | -5.95 | -4.02 | -273.10 | -3.59 | -5.81 | -58.63 | -11.71 | -249.50 | 285.22 | – |
| (EBITDA − CapEx) / Interest expense | – | – | – | -4.03 | -274.76 | – | -5.81 | -58.77 | -11.80 | -250.00 | 285.00 | – |
| Per share | ||||||||||||
| Revenue per share | 2.34 | 22.80 | 769.99 | 973.27 | – | – | – | – | – | – | – | – |
| EPS (basic) | 98.07 | 203.89 | 2,374.55 | 2,800.98 | 13,906.62 | 18.90 | 120.96 | 226.80 | 9.45 | 9.45 | 20.79 | – |
| EPS (diluted) | 98.07 | 203.89 | 2,374.55 | 2,800.98 | 13,906.62 | 20.79 | 120.96 | 226.80 | 9.45 | 9.45 | 20.79 | – |
| Book value per share | 11.60 | 142.32 | 2,036.37 | 4,659.68 | 497.68 | 260.66 | 0.23 | 0.25 | 11.33 | 2.64 | 9,166.67 | – |
| Tangible book value per share | 8.40 | 116.51 | 1,183.47 | 1,251.45 | 497.68 | 260.66 | 0.23 | 0.25 | 11.33 | 2.64 | 9,166.67 | – |
| Cash per share | 12.56 | 26.88 | 555.23 | 2,582.37 | 420.28 | 354.72 | 14.37 | 2.00 | 12.42 | 3.12 | 12,484.13 | – |
| Operating cash flow per share | -11.32 | -89.09 | -1,574.49 | -5,720.38 | -309.39 | -785.09 | -77.59 | -9.61 | -6.19 | -6.80 | -11,134.92 | – |
| Free cash flow per share | – | – | – | -5,726.16 | -311.53 | – | -77.60 | -9.63 | -6.25 | -6.81 | -11,150.79 | – |
| CapEx per share | – | – | – | 5.78 | 2.14 | – | 0.02 | 0.02 | 0.06 | 0.02 | 15.87 | – |
| Valuation at period end | ||||||||||||
| Market cap | $727.07K | $1.29M | $1.38M | $102.52K | $14.14M | – | – | – | – | – | – | – |
| Enterprise value | -$116.93K | $2.77M | $1.98M | -$12.84M | $6.55M | – | – | – | – | – | – | – |
| P/S | 0.8x | 1.0x | 0.5x | 0.1x | – | – | – | – | – | – | – | – |
| P/B | 0.2x | 0.2x | 0.2x | 0.0x | 1.7x | – | – | – | – | – | – | – |
| P/TBV | 0.2x | 0.2x | 0.3x | 0.1x | 1.7x | – | – | – | – | – | – | – |
| P/Gross profit | 1.2x | 2.6x | 0.6x | 0.1x | – | – | – | – | – | – | – | – |
| P/OCF | -0.2x | -0.3x | -0.2x | -0.0x | -2.8x | – | – | – | – | – | – | – |
| EV/Sales | -0.1x | 2.1x | 0.7x | -9.5x | – | – | – | – | – | – | – | – |
| EV/Gross profit | -0.2x | 5.5x | 0.9x | -12.5x | – | – | – | – | – | – | – | – |
| EV/EBITDA | 0.0x | – | – | 1.6x | – | – | – | – | – | – | – | – |
| EV/EBIT | 0.0x | – | – | 1.5x | – | – | – | – | – | – | – | – |
| EV/OCF | 0.0x | -0.5x | -0.3x | 1.6x | -1.3x | – | – | – | – | – | – | – |
| EV/FCF | – | – | – | 1.6x | – | – | – | – | – | – | – | – |
| Earnings yield | -1,675.1% | -486.8% | -371.2% | -2,528.2% | -41.0% | – | – | – | – | – | – | – |
| FCF yield | – | – | – | -7,730.0% | -36.0% | – | – | – | – | – | – | – |
| Cost structure | ||||||||||||
| R&D to revenue | 245.0% | 130.7% | 57.0% | 208.1% | – | – | – | – | – | – | – | – |
| SG&A to revenue | – | – | 174.7% | 443.4% | – | – | – | – | – | – | – | – |
| Stock-based comp to revenue | 101.3% | 43.6% | 6.8% | 66.6% | – | – | – | – | – | – | – | – |
| Per employee | ||||||||||||
| Total employees | 3 | 500 | 500 | 500 | 7 | 3 | 500 | 9 | 9 | 5 | 5 | 5 |
| Revenue per employee | $285.33K | $2.61K | $5.76K | $2.69K | – | – | – | – | – | – | – | – |
| Gross profit per employee | $210.33K | $1.01K | $4.39K | $2.05K | – | – | – | – | – | – | – | – |
| Operating profit per employee | -$2.79M | -$14.63K | -$13.63K | -$16.57K | -$824.00K | -$1.10M | -$8.22K | -$804.56K | -$639.33K | -$400.00K | $512.80K | – |
| Net income per employee | -$4.06M | -$12.57K | -$10.24K | -$5.18K | -$827.00K | $1.18M | $9.37K | $726.00K | $693.78K | $398.60K | $508.20K | – |
| Free cash flow per employee | – | – | – | -$15.85K | -$728.00K | – | -$9.39K | -$794.33K | -$513.67K | -$295.60K | -$281.00K | – |
| Growth | ||||||||||||
| Revenue 1Y growth | -34.5% | -54.6% | 113.7% | – | – | – | – | – | – | – | – | – |
| Revenue 3Y CAGR | -14.0% | – | – | – | – | – | – | – | – | – | – | – |
| Gross profit 1Y growth | 24.7% | -77.0% | 114.2% | – | – | – | – | – | – | – | – | – |
| Gross profit 3Y CAGR | -14.9% | – | – | – | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | -14.5% | -7.4% | 17.8% | -43.7% | -75.2% | 19.8% | 43.3% | -25.8% | -187.7% | -178.0% | – | – |
| EBITDA 1Y growth | -19.1% | -8.9% | 22.5% | -41.2% | -83.3% | 20.4% | 44.6% | -23.4% | -188.0% | -177.8% | – | – |
| Net income 1Y growth | -93.8% | -22.7% | -97.6% | 55.2% | -263.8% | -24.6% | -28.3% | 4.6% | 213.3% | -21.6% | – | – |
| Net income 3Y CAGR | – | – | – | – | – | -17.3% | 33.0% | 37.0% | – | – | – | – |
| Net income 5Y CAGR | – | – | – | – | – | 6.8% | – | – | – | – | – | – |
| Diluted EPS 1Y growth | -51.9% | -91.4% | -15.2% | -79.9% | 66,790.9% | -82.8% | -46.7% | 2,300.0% | 0.00% | -54.5% | – | – |
| Diluted EPS 3Y CAGR | -67.3% | -75.5% | 385.2% | 185.0% | 294.3% | 30.1% | 133.9% | 121.8% | – | – | – | – |
| Diluted EPS 5Y CAGR | 36.4% | 11.0% | 60.0% | 212.2% | 330.1% | 0.00% | – | – | – | – | – | – |
| Diluted EPS 10Y CAGR | 16.8% | – | – | – | – | – | – | – | – | – | – | – |
| Operating cash flow 1Y growth | 18.9% | 13.3% | 25.6% | -56.4% | -17.5% | 8.3% | 34.2% | -55.8% | -210.7% | -5.1% | – | – |
| Free cash flow 1Y growth | – | – | – | -55.5% | – | – | 34.3% | -54.6% | -212.8% | -5.2% | – | – |
| CapEx 1Y growth | – | – | – | -77.1% | – | – | -94.1% | -61.4% | 1,000.0% | 100.0% | – | – |
| CapEx 3Y CAGR | – | – | – | 100.0% | 27.2% | – | -37.0% | 104.1% | – | – | – | – |
| CapEx 5Y CAGR | – | – | – | -28.9% | 54.3% | – | – | – | – | – | – | – |
| Total assets 1Y growth | -26.3% | -7.5% | 5.4% | 6.9% | 287.2% | 121.9% | -74.7% | -52.3% | 668.4% | – | – | – |
| Total assets 3Y CAGR | -10.4% | 1.4% | 63.4% | 109.5% | 29.6% | -35.5% | -2.5% | – | – | – | – | – |
| Total assets 5Y CAGR | 24.4% | 55.1% | 19.6% | 2.1% | 51.4% | – | – | – | – | – | – | – |
| Total equity 1Y growth | -48.0% | 7.1% | 18.1% | – | – | 10,114.3% | -92.4% | -97.8% | – | – | – | – |
| Total equity 3Y CAGR | -13.1% | – | 74.6% | 672.3% | – | -44.6% | – | – | – | – | – | – |
| Total equity 5Y CAGR | 24.3% | 257.3% | 110.3% | -5.1% | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.